Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Practice the motion of injection without completing it
Semaglutide works by mimicking GLP-1 (glucagon-like peptide-1)
For instance, in August 2025, Viking Therapeutics, a US-based company specializing in metabolic and endocrine disorder treatments, announced positive top-line results from its Phase 2 VENTURE-Oral Dosing trial of VK2735, an investigational oral dual GLP-1/GIP agonist for obesity
Researchers can assess the stability and compatibility of the drug within the receptor
GIP receptor activation enhances fat metabolism, improves lipid profiles, and may contribute to the superior weight loss results seen in clinical trials
US$ 22.91
US$ 26.52
US$ 20.11
US$ 20.43
US$ 25.55
US$ 24.52
